This maddening sideways chop continues and the best “risk on” sector, biotech, looks heavy and tired. The leaders in this space are heavy, AMGN has a bearish head and shoulder pattern going on and CELG and BIIB just cant stop stepping on their feet. GILD acts the best of the big four biotechs. The other biggie, REGN, continues to hang on so far.